Thu, August 11, 2022

Joseph Schwartz Maintained (ASND) at Buy with Decreased Target to $168 on, Aug 11th, 2022

Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $174 to $168 on, Aug 11th, 2022.

Joseph has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joseph


  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $158 on, Thursday, May 12th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $176 on, Thursday, May 12th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $123 on, Thursday, May 12th, 2022